The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study
Background. Inflammatory breast cancer (IBC) is a rare but most aggressive breast cancer subtype. The impact of locoregional therapy on survival in IBC is controversial. Methods. Patients with nonmetastatic IBC between 1988 and 2013 were identified in the Surveillance, Epidemiology, and End Results...
Saved in:
Main Authors: | Mahvish Muzaffar, Helen M. Johnson, Nasreen A. Vohra, Darla Liles, Jan H. Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2018/6438635 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
by: M.C. Van Maaren, et al.
Published: (2025-02-01) -
The Role of Nonmetastatic Lymph Nodes in the Survival of Colorectal Cancer: A Systematic Review
by: Alexander J. Pennings, MSc, et al.
Published: (2023-12-01) -
Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels
by: Jun Takahashi, et al.
Published: (2018-01-01) -
Survival after Abdominoperineal and Sphincter-Preserving Resection in Nonmetastatic Rectal Cancer: A Population-Based Time-Trend and Propensity Score-Matched SEER Analysis
by: Rene Warschkow, et al.
Published: (2017-01-01) -
Predictors of Long-Time Survivors in Nonmetastatic Colorectal Signet Ring Cell Carcinoma: A Large Population-Based Study
by: Wuguang Zhang, et al.
Published: (2022-01-01)